Global Psoriatic Arthritis Treatment Market Size By Type of Treatment, By Drug Class, By Patient Demographics, By Geographic Scope And Forecast

Psoriatic Arthritis Treatment Market Size And Forecast

The global Psoriatic Arthritis Treatment Market size is valued at USD 7.81 Billion in 2023 and is projected to reach USD 13.12 Billion by 2030, growing at a CAGR of 9.4% during the forecast period 2024-2030.

Global Psoriatic Arthritis Treatment Market Drivers

The “Psoriatic Arthritis Treatment Market” is influenced by several market drivers, which are factors that contribute to its growth and expansion. These drivers include

• Increasing Prevalence of Psoriatic Arthritis As the incidence of psoriatic arthritis continues to rise, there is a growing patient population in need of treatment. This trend drives the demand for psoriatic arthritis treatments.
• Advancements in Medical Research Ongoing research and development efforts lead to the discovery of new and more effective treatments for psoriatic arthritis, which can boost the market. These may include innovative pharmaceuticals, biologics, and targeted therapies.
• Aging Population The aging population is more susceptible to various autoimmune diseases, including psoriatic arthritis. As the global population continues to age, the demand for psoriatic arthritis treatment is likely to increase.
• Increased Awareness Greater awareness about psoriatic arthritis, its symptoms, and available treatments can lead to earlier diagnosis and treatment, thereby driving market growth.
• Improved Diagnosis Advances in diagnostic techniques and tools enable healthcare professionals to identify psoriatic arthritis more accurately and at an earlier stage, facilitating timely treatment.
• Biologic Therapies The development and adoption of biologic therapies, which specifically target the immune system and inflammatory pathways, have provided more effective and personalized treatment options for psoriatic arthritis.
• Healthcare Infrastructure Development Improvements in healthcare infrastructure, especially in emerging markets, can enhance patient access to psoriatic arthritis treatment, leading to market expansion.
• Patient-Centric Approaches The shift toward patient-centric healthcare and personalized medicine has led to the development of treatments that cater to individual patient needs and preferences, driving demand in the market.
• Stricter Regulations Stringent regulatory standards and guidelines for the approval of psoriatic arthritis treatments ensure product safety and efficacy, giving patients and healthcare providers more confidence in these treatments.
• Market Competition Intense competition among pharmaceutical companies and biotechnology firms in the psoriatic arthritis treatment space encourages the development of new therapies and drives innovation.

Global Psoriatic Arthritis Treatment Market Restraints

Numerous obstacles and limitations in the market could prevent the “Psoriatic Arthritis Treatment Market” from expanding. Among these limitations are

• High Treatment Costs Many psoriatic arthritis treatments, especially biologics and targeted therapies, can be expensive. Exorbitant treatment expenses may prevent some patients from receiving care and strain healthcare systems financially.
• Limited Treatment Options While there have been advancements in psoriatic arthritis treatments, some patients may not respond to existing therapies, and there remains a need for more diverse and effective treatment options.
• Side Effects and Safety Concerns Some psoriatic arthritis treatments, including biologics, can have side effects and safety concerns. Patients and healthcare providers may be cautious about using these treatments due to potential risks.
• Lack of Disease Awareness In some regions, awareness about psoriatic arthritis remains low, leading to delayed diagnosis and treatment. This can hinder market growth by limiting the patient pool.
• Complex Diagnosis Psoriatic arthritis can be challenging to diagnose, as its symptoms can overlap with other conditions. The complexity of diagnosis may result in delayed treatment.
• Healthcare Disparities Access to high-quality care and treatments for psoriatic arthritis may be hampered by healthcare disparities, particularly in less developed areas or among underprivileged populations.
• Regulatory Obstacles Tight regulations pertaining to medication approval may impede the release of novel treatments for psoriatic arthritis.
• R&D Costs Substantial research and development is required to create and introduce novel treatments for psoriatic arthritis. Pharmaceutical companies may be discouraged from investing in the field by these costs.
• Generic Competition As patents for existing psoriatic arthritis treatments expire, generic versions can enter the market, leading to lower prices and reduced revenue for brand-name drugs.
• Comorbid Conditions Psoriatic arthritis often occurs alongside other medical conditions, such as psoriasis, which can complicate treatment and management.

Global Psoriatic Arthritis Treatment Market Segmentation Analysis

The Global Psoriatic Arthritis Treatment Market is segmented on the basis of Type of Treatment, Drug Class, Patient Demographics, and Geography.

Psoriatic Arthritis Treatment Market, By Type of Treatment

• Pharmaceutical TreatmentMedications and drugs prescribed to manage psoriatic arthritis symptoms, including nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and biologics.
• Physical Therapy and RehabilitationNon-pharmaceutical treatments, including physical therapy, exercise, and joint-specific therapies to improve joint function and reduce pain.
• SurgerySurgical interventions, such as joint replacement surgery, for patients with severe joint damage or deformity.

Psoriatic Arthritis Treatment Market, By Drug Class

• Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)Medications used to relieve pain and inflammation in psoriatic arthritis.
• Disease-Modifying Antirheumatic Drugs (DMARDs)Medications that slow down the progression of psoriatic arthritis and reduce joint damage.
• BiologicsA class of drugs that target specific components of the immune system to control inflammation and slow the progression of psoriatic arthritis.
• CorticosteroidsAnti-inflammatory medications that can be used to reduce inflammation and manage symptoms.
• Non-Biologic Disease-Modifying DrugsDMARDs that are not biologics, such as methotrexate.
• OthersOther drug classes and emerging therapies for psoriatic arthritis.

Psoriatic Arthritis Treatment Market, By Patient Demographics

• AdultsThe majority of psoriatic arthritis patients are adults, and treatment options are primarily developed for this demographic.
• Pediatric and Adolescent PatientsPsoriatic arthritis can affect children and adolescents, and specialized treatment may be required for this age group.
• Elderly PatientsOlder adults with psoriatic arthritis may have specific treatment needs and considerations.

Psoriatic Arthritis Treatment Market, By Geography

• North AmericaMarket conditions and demand in the United States, Canada, and Mexico.
• EuropeAnalysis of the Psoriatic Arthritis Treatment Market in European countries.
• Asia-PacificFocusing on countries like China, India, Japan, South Korea, and others.
• Middle East and AfricaExamining market dynamics in the Middle East and African regions.
• Latin AmericaCovering market trends and developments in countries across Latin America.

Key Players

The major players in the global Psoriatic Arthritis Treatment Market include

• AbbVie
• Amgen
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celgene
• Eli Lilly and Company
• Johnson & Johnson
• Merck & Co.
• Novartis
• Pfizer
• UCB
• Sun Pharmaceutical Industries Ltd.
• Astellas Pharma Inc.
• GlaxoSmithKline plc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Zymeworks Inc.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.